Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker CPAY
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 4, 2026 | CPAY Corpay, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 5, 2026 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 5, 2026 | CPAY Corpay, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 24, 2026 | CPAY Corpay, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 22, 2026 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 22, 2026 | CPAY Corpay, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 12, 2026 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 12, 2026 | CPAY Corpay, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2026 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 7, 2026 | CPAY Corpay, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 27, 2026 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 26, 2026 | CPAY Corpay, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 26, 2026 | CPAY Corpay, Inc. | 5.08 Shareholder Director Nominations | 8-K | 8-K ↗ |
| Feb 5, 2026 | CPAY Corpay, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K/A | 8-K ↗ |
| Feb 4, 2026 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 4, 2026 | CPAY Corpay, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 22, 2026 | CPAY Corpay, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 5, 2025 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 5, 2025 | CPAY Corpay, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Nov 5, 2025 | CPAY Corpay, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 5, 2025 | CPAY Corpay, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Nov 5, 2025 | CPAY Corpay, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Sep 29, 2025 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 6, 2025 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 6, 2025 | CPAY Corpay, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 23, 2025 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 23, 2025 | CPAY Corpay, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jul 23, 2025 | CPAY Corpay, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 16, 2025 | CPAY Corpay, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 10, 2025 | CPAY Corpay, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 6, 2025 | CPAY Corpay, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 6, 2025 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 6, 2025 | CPAY Corpay, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 29, 2025 | CPAY Corpay, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 17, 2025 | CPAY Corpay, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 5, 2025 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 5, 2025 | CPAY Corpay, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 3, 2024 | CPAY Corpay, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 7, 2024 | CPAY Corpay, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 7, 2024 | CPAY Corpay, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 28, 2024 | CPAY Corpay, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 28, 2024 | CPAY Corpay, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
43 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:20 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances